Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Símbolo:
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
08/10/202402:00Business WireRisky Business: 86% of Industry Visionaries Believe Risk Takers Make Better Leaders, Elixirr ReportsLSE:ELIXElixirr International Plc
08/10/202402:00Business WireAirship Ushers in New Era Of Agility for Brands to Unify and Optimise End-to-End Customer Experiences Across Websites, Apps and All Channels
08/10/202402:00Business WireCinemo and Renault Korea Enable Premium Entertainment for Newly Launched SUV
08/10/202402:00Business WireDeutsche Telekom IT Revolutionizes Digital Experiences with DynatraceNYSE:DTDynatrace Inc
08/10/202402:00Business WireOfficina Stellare and Skyloom Global Corp Sign Letter of Intent to Establish Italian-based Joint Venture Skyloom Europe
08/10/202402:00Business WireFPT Software and GigaX Join Forces to Drive Digital Transformation and Sustainability across Europe
08/10/202402:00PR Newswire (US)Regenerative Agriculture Explored on All Access with Andy Garcia
08/10/202402:00PR Newswire (US)Whitman-Walker Foundation to Honor Matt Voorhees with the Groundbreaker Award for Community Philanthropy
08/10/202402:00PR Newswire (US)SAP Supercharges Copilot Joule with Collaborative Capabilities to Ignite Enterprise AI RevolutionNYSE:SAPSAP SE
08/10/202402:00PR Newswire (US)Expo City Dubai unveils new master plan, placing it at the centre of Dubai's future growth
08/10/202402:00PR Newswire (US)IGS to Exhibit at "Battery Show North America 2024" Innovative Non-destructive Battery Diagnosis System Enabling All-cell Inspection and Zero Battery Ignition
08/10/202402:00PR Newswire (US)Aprecomm Enhances its Software Stack with TR-369 to Provide a Standards-based Approach to Device Management
08/10/202402:00PR Newswire (US)Buyers Edge Platform Acquires Parsly, Expanding Their Technology Offerings for European Restaurants
08/10/202402:00PR Newswire (US)CS Analytical Issues Guidance on Pending USP 661.1 and USP 661.2 Implementation Date
08/10/202402:00PR Newswire (US)Service Providers IPNET and Petcom Partner with Aprecomm to Enhance Online Experiences in Brazil
08/10/202402:00PR Newswire (US)Genezen Appoints Mike Wourms as Chief Operations Officer
08/10/202402:00PR Newswire (US)LF Broadband Partners With Broadband Forum to Enable Disaggregated Open Source Access Networks Solutions
08/10/202402:00PR Newswire (US)Aprecomm Teams up with Qualcomm to Boost Network Application Intelligence
08/10/202402:00PR Newswire (US)"Empowered with Meg Ryan" Partners with Nine Minds on New Episode Exploring AI Integration in the IT Sector
08/10/202401:57Business WireLes Luxembourg Venture Days réuniront investisseurs, startups et innovateurs les 16 et 17 octobre 2024
08/10/202401:57Business WireLuxembourg Venture Days riunirà investitori, start-up e innovatori il 16 e 17 ottobre 2024
08/10/202401:57Business WireLuxembourg Venture Days am 16. und 17. Oktober 2024 führen Investoren, Start-ups und Innovatoren zusammen
08/10/202401:54PR Newswire (US)7 Highlights Unveiled for the Upcoming Hongqiao International Economic Forum
08/10/202401:53Alliance NewsAlliance NewsUK watchdog slaps penalty on water firms for missing targets
08/10/202401:52Alliance NewsAlliance NewsLONDON BRIEFING: Imperial Brands lifts returns; Vistry warns on profit
08/10/202401:40GlobeNewswire Inc.Zealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for survodutide
08/10/202401:39Business WireDecarbonizing French Industry: TotalEnergies Signs a Renewable Electricity Supply Agreement with Saint-GobainNYSE:TTETotalEnergies SE
08/10/202401:39Business WireDécarbonation de l’industrie en France : TotalEnergies signe un contrat de vente d’électricité renouvelable avec Saint-GobainNYSE:TTETotalEnergies SE
08/10/202401:39PR Newswire (US)Nobel Prize in Literature: Odds Favorites Revealed by Swedish Betting Giant Betsson
08/10/202401:35GlobeNewswire Inc.Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide